Patent · US Active

Crystalline forms of rapamycin analogs

US7812032B2 · kind B2 · utility

6Cited by

1References

18Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Shekhar Viswanath · Maryland Heights, US
Larry Bartelt · Highland Park, US
Robert Leanna · Grayslake, US
Michael Dolberg Rasmussen · Kenosha, US
Madhup K. Dhaon · Mundelein, US
Rodger F. Henry · Park City, US
Thomas B. Borchardt · Kenosha, US
Shuang Chen · Gurnee, US
Geoff G. Zhang · Vernon Hills, US

Key dates

Filing date	Jul 23, 2007
Grant date	Oct 12, 2010
Priority date	—
Expiry date	Apr 15, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A rapamycin analog composition includes a crystalline form of a rapamycin analog. The crystal can be a hydrate, dehydrate, solvate, or desolvate. The rapamycin analog can have a structure of Formula 1, which is optionally a prodrug, salt, derivative, or combination thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.